Calcitonin gene products and the kidney by Kurtz, Armin et al.
Klin Wochenschr (1989) 67:870-875 
Kiinische 
W°chenchrif t 
© Springer-Verlag 1989 
Calcitonin Gene Products and the Kidney 
A. Kurtz 1, R. Muff z, and J.A. Fischer z
1 Physiologic Institute, University of Ziirich, Switzerland 
2 Research Laboratory for Calcium Metabolism, Departments ofOrthopedic Surgery and Medicine, University of Ziirich, 
Ziirich, Switzerland 
Summary. Calcitonin gene-related peptide (CGRP) 
is localized in capsaicin-sensitive nerve fibres in the 
kidney and urogenital tract whereas calcitonin 
reaches the kidney through the general circulation. 
Systemic infusion of CGRP and perfusion of iso- 
lated rat kidney reduces vascular esistance, and 
increases renal blood flow and glomerular filtra- 
tion. CGRP stimulates renin secretion in vivo and 
in vitro and inhibits contraction of isolated rat me- 
sangial cells by angiotensin II. Calcitonin does not 
affect vascular resistance, renal blood flow and glo- 
merular filtration, and is tess potent in stimulating 
renin secretion, and does not alter contraction of 
isolated rat mesangial cells by angiotensin II. 
CGRP also exerts renal tubular effects brought 
about probably through interaction with calcitonin 
receptors. To this end, increased excretion of sodi- 
um and chloride, and stimulation of urinary flow 
are less pronounced with CGRP than with calcito- 
nin. Calcitonin, moreover, stimulates the fractional 
urinary excretion of calcium and phosphate. 
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Alternative splicing of the initial calcitonin gene 
transcript results in the formation of two distinct 
messenger RNAs encoding the precursors of calci- 
tonin and of calcitonin gene-related peptide 
(CGRP) [2, 26]. In man and rat two calcitonin/ 
CGRP genes have been recognized [3, 40]. A pseu- 
dogene encoding a second calcitonin-like structure 
appears not to be expressed in man [40]. But 
CGRP-I (or 7) and -II (or fl) have been identified 
in man and rat at the mRNA and peptide levels 
[3, 23, 341. 
Calcitonin and CGRP are single chain polypep- 
tides consisting of 32 and 37 amino acids, respec- 
tively. They have in common amino-terminal ring 
structures linked by disulfide bridges and the car- 
boxyltermini are amidated. In man, CGRP shares 
16% structural homology with calcitonin whereas 
the homology between CGRP-I and -II is 92% 
[13]. As a result, distinct receptors for calcitonin 
and CGRP have been identified [7, 11, 33, 42]. 
Human CGRP-I and -II, due to their high homolo- 
gy, crossreact almost completely, but subtle differ- 
ences in the distribution of human CGRP-I and 
-II binding sites have been observed on receptor 
autoradiography of the human brain [22]. 
Calcitonin is predominantly s nthesized and re- 
leased from thyroid C-cells [15]. An important sti- 
mulator of calcitonin secretion is an increase in 
the extracellular calcium concentration [36]. Calci- 
tonin can be considered as a hormone that reaches 
its target tissues via the circulation. Calcitonin 
lowers serum calcium levels through inhibition of 
bone resorption [37]. In the kidney, calcitonin sti- 
mulates the urinary excretion of calcium, phos- 
phate, sodium, potassium and chloride, and en- 
hances 1,25-dihydroxycholecalciferol p duction 
[5, 20, 25, 32]. 
CGRP is predominantly s nthesized in the ner- 
vous system and is frequently found in peripheral 
nerves associated with blood vessels, but CGRP 
has also been identified in the normal human thy- 
roid gland and in thyroid C-cells [17, 21, 41]. Much 
like the secretion of calcitonin, the release of 
CGRP from C-cells is stimulated by raised extra- 
cellular calcium concentrations [21]. In vivo serum 
levels of CGRP only minimally respond to changes 
of the extracellular calcium concentration and 
probably largely represent a spillover from the ner- 
vous system [6]. Plasma levels of CGRP are re- 
duced in capsaicin-treated rats suggesting that cir- 
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Table 1. Effects of CGRP and calcitonin in the kidney 
CGRP Caleitonin 
Relaxation 
Vascular smooth muscle cells + + 0 
Mesangial cells + + 0 
Ureter + + ND 
Renal blood f low + " 0 
Glomerular f i ltration rate + ~ 0 
Renin secretion + + 0 
Tubular function 
Urinary flow + ~ + + 
Fractional excretion (Na, C1) + a + + 
(Ca, P04) 0 -k -k 
a arterial pressure maintained: ND:  not done 
culating CGRP originates in part from the sensory 
nervous ystem [10]. The most prominent effects 
of CGRP are on the cardiovascular system where 
CGRP is a potent vasodilator and exerts positive 
chronotropic and inotropic actions on the heart 
[8, 14, 161. 
In the present review we have compared the 
renal effects of CGRP and calcitonin in vivo and 
in vitro (Table 1). 
Localization of CGRP in the Kidney 
and Urogenital Tract 
CGRP containing nerve fibres have been localized 
in kidneys of rat and guinea pigs [29, 35]. Within 
the kidney the density of CGRP positive fibres is 
highest in the muscular layer of the renal pelvis. 
Immunoreactive n rve fibres are also recognized 
in the proximity of arteries and arterioles (includ- 
ing the juxtaglomerular pparatus) and in the per- 
iglomerular and peritubular space (Fig. 1). Reduc- 
tion of CGRP containing rat renal nerve fibres 
following treatment with capsaicin inferres asenso- 
ry origin [17, 29]. CGRP immunoreactive n rve 
fibres abolished with capsaicin are, moreover, 
abundant in the ureter and bladder [19]. 
Renovascular Effects 
Effects of CGRP on renal blood flow and on renal 
vascular esistance have been examined in vivo in 
man, rats, dogs and rabbits. In anesthetized rats 
graded amounts of rat CGRP-~ lead to a dose- 
dependent fall of the renal vascular esistance and 
a simultanous increase of renal blood flow, which 
is associated with reduced mean arterial blood 
pressure [44]. In the dog renal blood flow and glo- 
merular filtration are increased [43]. In man and 
rabbits ystemic nfusion of CGRP reduces arterial 
pressure, and effective renal plasma nd blood flow 
[4, 29]. Since in vivo reduction of arterial pressure 
may reduce renal blood flow, effects of CGRP on 
the isolated rat kidney perfused at constant pres- 
sure have also been examined [30]. In this prepara- 
tion rat CGRP-e reduces vascular esistance and 
blunts the vasoconstrictory effect of angiotensin 
II. In the isolated perfused rat kidney CGRP more- 
over increases the glomerular filtration rate and 
the glomerular filtration fraction and urinary flow 
[30]. 
In vitro CGRP blunts the contraction of me- 
sangial cells obtained with angiotensin II [30]. Re- 
laxation of mesangial cells by CGRP is consistent 
with the increased filtration fraction observed in 
vivo and in vitro. The effects of CGRP in isolated 
rat mesangial cells are presumably mediated by ra- 
ised cAMP production, which was also observed 
in blood vessels [12, 27]. cAMP production prob- 
ably mediates the dilatory effect of CGRP in me- 
sangial cells and presumably renal vascular smooth 
muscle cells. Calcitonin, on the other hand, does 
not affect cAMP formation in mesangial cells. Evi- 
dence was obtained that CGRP does not interfere 
with the calcium mobilization by angiotensin II
in mesangial cells, suggesting that the dilatory ef- 
fect of CGRP is caused by other mechanisms e.g. 
inactivation of the myosin light chain kinase [1, 
30]. 
Taken together the results demonstrate hat 
CGRP causes vasodilation of renal blood vessels 
and increases glomerutar filtration. In the absence 
of calcitonin receptors in renal glomeruli and me- 
sangial cells it would seem that CGRP exerts direct 
renovascular effects through interaction with spe- 
cific receptors [29, 30, 32, 39]. 
Renotubular Effects 
Calcitonin exerts pronounced tubular effects uch 
as the enhancement of he urinary fractional excre- 
tion of sodium, chloride, potassium, calcium and 
phosphate, and stimulation of urinary flow [5, 20, 
32]. 
Tubular effects of systemic infusions of 
hCGRP-II have been examined in humans (Gn/id- 
inger et al., submitted for publication). The frac- 
tional excretion of sodium and chloride is raised, 
but less pronounced than with equimolar amounts 
of calcitonin. The urinary flow and the fractional 
excretion of calcium and phosphate are not af- 
fected by CGRP. Lowered excretion of sodium and 
potassium and reduction of urinary flow was 
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Fig. 1. Immunofluorescence micrographs from rat kidney sections after incubation with antiserum to rat CGRP~. Pelvis region 
(a and d), cortex region (b, e, e, and f). Control animals (a-e, e, and f) and capsaicin-pretreated animals (d). A dense network 
of CGRP-immunoreactive nerve fibres is seen in the pelvis muscle and close to epithelium (ep) of the control rat, whereas most 
of the CGRP-immunoreactive n rve profiles disappeared after capsaicin treatment. CGRP-immunoreactive fibres (arrowheads) 
are also present around (b) small arteries (~k'), (e) among tubules, and (e and f) close to glomeruli (~) with associated arterioles. 
Bars, 50 gm. (From reference [29]; reproduced from the Journal of Clinical Investigation, 1988, vol 82, p 541 by copyright 
permission of the American Society of Clinical Investigation) 
found with CGRP infusions in anesthetized rats, 
but mean arterial blood pressure was also reduced 
[44]. Interference of hypotension with tubular func- 
tion seems probable. In the isolated rat kidney, 
however, perfused at constant pressure, enhance- 
ment of sodium excretion by CGRP and increased 
urinary flow are observed [30]. 
In cloned renal porcine tubular LLC-PK1 cells 
calcitonin was more potent than CGRP in stimu- 
lating the production of cAMP and plasminogen 
activator [45]. Since calcitonin and CGRP exert 
similar tubular effects, it appears likely that CGRP 
interacts with calcitonin receptors localized on re- 
nal tubules [32]. 
Renoendocrine Effects 
Renin and erythropoietin are released by the kid- 
ney and regulate blood pressure, extracellular vol-
ume and erythropoiesis. Their regulation of secre- 
tion by CGRP has been examined in man and rats. 
Infusions of CGRP-I I  in man cause increased plas- 
ma renin activity which indicates stimulation of 
renal renin release [29]. At the same time the arteri- 
al blood pressure was reduced. It was therefore 
difficult to distinguish between a direct stimulatory 
action of CGRP on renal juxtaglomerular cells 
raising renin production and an indirect hypoten- 
sire effect also stimulating renin secretion. 
In the isolated rat kidney, however, perfused 
at constant pressure (100 mm Hg) rat CGRP-~ 
causes a potent stimulation of renin secretion [30]. 
Furthermore, CGRP stimulates renin release from 
isolated renal juxtaglomerular cells [29]. Rat calci- 
tonin is ineffective on juxtaglomerular cells, but 
the more potent salmon calcitonin stimulates r nin 
release, albeit at concentrations that are 20-fold 
higher than those of rat CGRP-g. Salmon calcito- 
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nin, moreover, stimulates renin secretion in rats, 
without concomitant changes of systemic arterial 
pressure [9]. The effects of rat CGRP-~ are me- 
diated through cAMP formation obtained in iso- 
lated renal juxtaglomerular cells with the same 
concentration dependence than renin secretion 
[29]. Since cAMP is an established stimulatory sec- 
ond messenger for renin secretion it appears likely 
that CGRP enhances renin secretion through acti- 
vation of adenylate cyclase in juxtaglomerular 
cells. 
Unlike renin that is stored in secretory gran- 
ules, the renal secretion of erythropoietin s con- 
trolled by the rate of de novo synthesis which in 
turn depends on the transcriptional ctivity of the 
erythropoietin gene [28]. Therefore, a delay of 
60 min between the onset of stimulation and initial 
rise of serum levels of erythropoietin s observed. 
Administration of hCGRP-I and -II in man in 
amounts timulating renin secretion did not alter 
erythropoietin levels up to t20 min after the start 
of the CGRP infusions (Kurtz, unpublished). It 
seems therefore that CGRP does not affect renal 
erythropoietin formation. 
Renal Smooth Muscle 
The smooth muscle layer in the renal pelvis is den- 
sely innervated with CGRP immunoreactive n rve 
fibres, but possible effects of CGRP remain to be 
examined. CGRP inhibits the spontaneous activity 
of the smooth musculature of the ureter causing 
dilation [1 A, 24, 31]. Since the smooth muscle layer 
of the ureter originates from the renal pelvis it ap- 
pears possible that CGRP also exerts a dilatory 
effect on the renal pelvis. 
Physiological Relevance of the Renal Effects 
of CGRP and Calcitonin 
The understanding of the physiological effects of 
CGRP is hampered by the lack of knowledge along 
which route CGRP comes into contact with its 
target cells. Since CGRP is localized in nerve fibres 
in the vicinity of blood vessels, glomeruli and renal 
tubules, CGRP is probably locally released from 
nerve fibres. Treatment with capsaicin released 
CGRP presumably originating from sensory nerve 
fibres in the kidney. Capsaicin also enhanced the 
release of CGRP in calcium-dependent manner 
from the rat spinal cord and the heart [17, 18, 
38]. Raised tension is a well established stimulator 
of afferent nerve fibres. To this end, increased in- 
trapelvical volume and pressure nhance the ten- 
sion of the smooth musculature of the pelvis and 
thus activate afferent nerve fibres. This may result 
in pain sensation, and presumably in the release 
of CGRP which in turn reduces the spontaneous 
activity of the renal pelvis causing dilation, and 
thus counteracts he painful contraction. 
The possible role of CGRP released from nerve 
fibres present in the renal cortex is less evident. 
Increased interstitial pressure could activate the 
nerve fibres and cause release of CGRP. This may 
also explain why increased renal interstitial pres- 
sure is associated with stimulation of renin secre- 
tion. 
Renal tubular effects such as the stimulation 
of the fractional urinary excretion of calcium, 
phosphate, sodium and potassium are presumably 
brought about through interaction with calcitonin 
receptors. Nevertheless, localized release of CGRP 
from nerve fibres may be physiologically as rele- 
vant as the interaction of calcitonin reaching the 
kidney tubules through the general circulation 
from the thyroid C-cells. 
CGRP may be important for the fine regula- 
tion of kidney function. Depending from which 
nerves CGRP is released, the neuropeptide may 
affect he renal vasculature directly, and exert indi- 
rect effects via the renin/angiotensin system. 
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